Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

71 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Primary prevention of acute respiratory tract infections in children using a bacterial immunostimulant: a double-masked, placebo-controlled clinical trial.
Jara-Pérez JV, Berber A. Jara-Pérez JV, et al. Among authors: berber a. Clin Ther. 2000 Jun;22(6):748-59. doi: 10.1016/S0149-2918(00)90008-0. Clin Ther. 2000. PMID: 10929921 Clinical Trial.
Participants were randomly allocated to receive either OM-85 BV or placebo for 10 consecutive days a month for 3 consecutive months. ...CONCLUSIONS: OM-85 BV had a preventive effect on ARTIs in the school girls, with a reduction in the antibiotic requirements …
Participants were randomly allocated to receive either OM-85 BV or placebo for 10 consecutive days a month for 3 consecutive months. …
Use of Broncho-Vaxom in private practice: phase IV trial in 587 children.
Berber AC, Del-Rio-Navarro BE. Berber AC, et al. Clin Ther. 1996 Nov-Dec;18(6):1068-79. doi: 10.1016/s0149-2918(96)80062-2. Clin Ther. 1996. PMID: 9001824 Clinical Trial.
We conducted a Phase IV, open-label clinical trial to test the efficacy and safety of the immunomodulating agent Broncho-Vaxom in private practice. The trial comprised 587 children younger than 12 years of age who had an acute respiratory tract infection at entry and a
We conducted a Phase IV, open-label clinical trial to test the efficacy and safety of the immunomodulating agent Broncho-Vaxom in pri …
Randomized, double blind, placebo-controlled clinical trial to evaluate the lymphagogue effect and clinical efficacy of calcium dobesilate in chronic venous disease.
Flota-Cervera F, Flota-Ruiz C, Treviño C, Berber A. Flota-Cervera F, et al. Among authors: berber a. Angiology. 2008 Jun-Jul;59(3):352-6. doi: 10.1177/0003319707305407. Epub 2008 Apr 2. Angiology. 2008. PMID: 18388097 Clinical Trial.
It was a randomized, placebo-controlled, double-blind clinical trial. Patients received 1 capsule of 500 mg calcium dobesilate every 8 hours (1.5 g/day) or placebo by 49 days. ...
It was a randomized, placebo-controlled, double-blind clinical trial. Patients received 1 capsule of 500 mg calcium dobesilate every …
[Efficacy of the immunoestimulant OM-BV85 in the Prevention of Respiratory Infections].
Del-Rio-Navarro B, Becerril-Ngeles M, Berber A. Del-Rio-Navarro B, et al. Among authors: berber a. Rev Alerg Mex. 2012 Jul-Sep;59(3):155-71. Rev Alerg Mex. 2012. PMID: 24007992 Spanish.
A recent study points to the utility of OM-BV85 in the treatment of children with wheezing secondary to repetitive respiratory infections. Although, there were immunostimulants with well defined mechanism of action in the future, currently OM-BV85 is a good option f
A recent study points to the utility of OM-BV85 in the treatment of children with wheezing secondary to repetitive respiratory infect
Cost-effectiveness analysis of OM-85 vs placebo in the prevention of acute respiratory tract infections (ARTIs) in children that attend day-care centers.
Berber A, Del-Rio-Navarro BE. Berber A, et al. Health Econ Rev. 2019 May 7;9(1):12. doi: 10.1186/s13561-019-0230-1. Health Econ Rev. 2019. PMID: 31065886 Free PMC article.
The high prevalence of overweight and obesity in Mexican children.
del Río-Navarro BE, Velázquez-Monroy O, Sánchez-Castillo CP, Lara-Esqueda A, Berber A, Fanghänel G, Violante R, Tapia-Conyer R, James WP; Encuesta Nacional de Salud 2000 Working Group, National Health Survey 2000. del Río-Navarro BE, et al. Among authors: berber a. Obes Res. 2004 Feb;12(2):215-23. doi: 10.1038/oby.2004.28. Obes Res. 2004. PMID: 14981213
Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
Sánchez-Reyes L, Fanghänel G, Yamamoto J, Martínez-Rivas L, Campos-Franco E, Berber A. Sánchez-Reyes L, et al. Among authors: berber a. Clin Ther. 2004 Sep;26(9):1427-35. doi: 10.1016/j.clinthera.2004.09.017. Clin Ther. 2004. PMID: 15531005 Clinical Trial.
Sibutramine is a serotonin- and norepinephrine-reuptake inhibitor that reduces food intake by inducing early satiety and attenuates the decrease in basal energy expenditure associated with weight loss. ...METHODS: This was a 12-month, randomized, double-blind, place …
Sibutramine is a serotonin- and norepinephrine-reuptake inhibitor that reduces food intake by inducing early satiety and attenuates t …
Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.
García-Morales LM, Berber A, Macias-Lara CC, Lucio-Ortiz C, Del-Rio-Navarro BE, Dorantes-Alvárez LM. García-Morales LM, et al. Among authors: berber a. Clin Ther. 2006 May;28(5):770-82. doi: 10.1016/j.clinthera.2006.05.008. Clin Ther. 2006. PMID: 16861099 Clinical Trial.
Using the intent-to-treat data, weight (mean [SD]) in the sibutramine group changed from 92.5 (14.6) kg to 85.7 (14.4) kg, for a net weight loss of 7.3 kg (95% CI 4.6-9.9), a waist circumference loss of 8.0 cm (95% CI, 4.7-11.3), and a % BMI loss of 9.2% (95% …
Using the intent-to-treat data, weight (mean [SD]) in the sibutramine group changed from 92.5 (14.6) kg to 85.7 (14.4) kg, for a net …
Safety and efficacy of sibutramine in overweight Hispanic patients with hypertension.
Fanghänel G, Cortinas L, Sánchez-Reyes L, Gómez-Santos R, Campos-Franco E, Berber A. Fanghänel G, et al. Among authors: berber a. Adv Ther. 2003 Mar-Apr;20(2):101-13. doi: 10.1007/BF02850257. Adv Ther. 2003. PMID: 12836810 Clinical Trial.
Following a 2-week washout to confirm the diagnosis of hypertension, antihypertensive medication was adjusted to achieve a blood pressure less than 140/90 mm Hg before institution of either sibutramine 10 mg or placebo once a day. A body mass index in …
Following a 2-week washout to confirm the diagnosis of hypertension, antihypertensive medication was adjusted to achieve a blo …
Use of OM-85 BV for the prevention of acute respiratory tract infections in occupational medicine.
Carmona-Ramírez MA, Alvárez-Gómez V, Berber A. Carmona-Ramírez MA, et al. Among authors: berber a. J Int Med Res. 2002 May-Jun;30(3):325-9. doi: 10.1177/147323000203000316. J Int Med Res. 2002. PMID: 12166352 Clinical Trial.
The patients were followed for a further 9 months. Mean number of ARTIs decreased from 8.2 +/- 2.1 per worker in 1999 to 5.3 +/- 2.9 in 2000; i.e. a difference of -2.9 (95% confidence intervals, -3.5 to -2.4). ...
The patients were followed for a further 9 months. Mean number of ARTIs decreased from 8.2 +/- 2.1 per worker in 1999 to 5.3 +/- 2.9 …
71 results
Jump to page
Feedback